• Thu, December 12, 2024

by: Moneyweb

Appetite for SA exposure stokes buying in JSE's stock

Merchant West Investments Pty, also known as Bridge Collective Investments RF Pty, is among the largest holders of JSE stock, according to data compiled by Bloomberg.

by: Sportsnet

Bills owner Pegula on Toronto after Carter, McGrady investments: 'That's our market'

Buffalo Bills majority owner Terry Pegula says three new minority investors with Toronto ties will help his team create further connections to one of North America's biggest markets.

by: The Daily Telegraph

This trust is a strong Rothschilds challenger - and it's on sale

It's early days for this old fund under a new manager but this is a good time to buy Questor is The Telegraph's stockpicking column, helping you decode the markets and offering insights on where to invest.

by: The Globe and Mail

Should You Buy This AI Stock Under $20 on Its Nvidia Partnership?

Last week, ZJK announced a strengthening of its partnership with Nvidia (NVDA) for AI-server liquid cooling systems. ZJK confirmed it had received a request to produce samples for a new liquid cooling manifold project.

by: CNN-News18

Stocks To Watch: Jubilant FoodWorks, Maruti Suzuki, Swiggy, SBI, Vedanta, And Others

Shares of firms like Jubilant FoodWorks, Maruti Suzuki, Swiggy, SBI, Vedanta, and others will be in focus on Thursday's trade

by: AOL

1 Unstoppable Vanguard ETF That Could Double Your Money in 2025 and Beyond

Building long-term wealth isn't necessarily easy, but investing in the stock market is one of the simplest ways to do it. While there's not necessarily a right or wrong place to invest, this Vanguard ETF could potentially double your money over time with next to no effort on your part.

by: Business Today

4 Factors You Must Know Before Investing In Internet-Based New-Age Tech Stocks

Zomato, and Swiggy are soaring, riding on a strong rally and capturing the spotlight in the stock market. While investors are capitalising on the buzz and momentum, it raises a vital question: should one focus solely on the growth and excitement,

by: The Motley Fool UK

The Nasdaq's almost doubled in the past 2 years! Here's what I think happens next

Jon Smith explains why the Nasdaq's done so well recently and flags up a specific stock he thinks could keep rallying.

by: The Motley Fool

2 Top Dividend Stocks to Buy and Hold Forever

Realty Income Corporation is a real estate investment trust (REIT), which is a type of corporation that's required to return most of its profits to shareholders in exchange for tax benefits. With an annualized return of 10.8% between 1992 and 2017, REITs consistently outperform stocks and bonds, making them a great pick for long-term investors.

by: 24/7 Wall St

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

Since the start of 2020, Eli Lilly's (NYSE: LLY) stock price chart has been straight up and to the right, up 502.16% and currently trading at $796.11. The company has been around since 1876 and the stock didn't go public until 1952 but in the last 4 years,

by: NBC New York

CNBC Daily Open: Alphabet and Tesla power Nasdaq to record highs

This report is from today's CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Like what you see?

by: Business Insider

Elon Musk becomes the first-ever person to be worth $400 billion

Elon Musk just keeps getting richer. And now, he's the first-ever person to hit the $400 billion mark. The Tesla and SpaceX CEO's net worth skyrocketed to $439.2 billion on Wednesday — an ...

by: Kiplinger

Why Uber Stock Is Volatile After GM's Cruise Announcement

Uber stock is swinging this week following news that General Motors is restructuring its Cruise unit. Here's what you need to know.

by: Yahoo Finance

Stock market today: Nasdaq tops 20,000 for first time as Big Tech surges, Tesla hits first record in 3 years

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/91.IM06wodO.js

by: 24/7 Wall St

The 20 Best AI ETFs to Buy Right Now

Demand for AI is exploding. Here are 20 AI-themed ETFs that investors can use to gain exposure to the nascent technology.

by: Seeking Alpha

Simplify's CTA: The Coveted Free Lunch

Diversification across asset classes mitigates risks and enhances portfolio resilience - the real "free lunch". See why I rate CTA ETF as a buy.

by: Kiplinger

Why Adobe Stock Is Down After Its Earnings Beat

Adobe stock is lower Thursday despite the tech giant beating expectations for its fiscal 2024 fourth quarter. Here's what you need to know.

by: The Motley Fool UK

I'm taking Warren Buffett's advice for when stocks are at record highs

Jon Smith looks back on some words of wisdom from Warren Buffett about how and where to invest as the market keeps rallying.

by: The Motley Fool

Will This Vital Semiconductor Company Make a Jaw-Dropping Comeback in 2025?

For 2030, management expects revenue to be 44 billion and 60 billion euros, representing an annual growth rate of 8% to 14%. Throw in a 1% dividend, stock buybacks, and margin expansion (which management predicts), and you have a recipe for a stock that can solidly beat the market.

by: Business Insider

The market is overlooking a key risk ahead of 2025: 'Stubbornly sticky' inflation

Inflation rose again in November, but the S&P 500 is at a record high. Here's why price growth sparked by tariffs could weigh down US stocks in 2025.

by: Business Today

Value Traps vs Value Stocks: How to Spot the Difference

Both may seem like bargains at first glance, value stocks often represent companies with strong fundamentals and future potential, whereas value traps are cheap for a reason—often due to deeper, unresolved issues.

by: Yahoo Finance

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

by: The Motley Fool

Down 12%, 12.5%, and 13% in 3 Months, Here Are 3 High-Yield Dividend King Stocks to Buy in December

With a 3.9% yield, Stanley Black & Decker stands out as an intriguing Dividend King to buy for investors who are confident about a recovery in consumer spending and have a long investment time horizon in case further delays hold the company back in the near term.

by: Kiplinger

How Do You Know When It's Time to Change Financial Advisers?

Sometimes a breakup is for the best. Here's how to handle 'the talk' and make the switch to a new professional who's a better fit for you.

by: Business Insider

One of Wall Street's biggest bulls sees the S&P 500 soaring 16% early next year before a sharp sell-off in the 2nd half

Fundstrat sees the S&P 500 hitting 7,000 in the middle of next year, followed by a correction that has the index ending 2025 at 6,600.

by: 24/7 Wall St

Does Billionaire Bill Gates Know Something Wall Street Doesn't? He Sold Microsoft Stock and Bought This Instead

Bill and Melinda French Gates officially divorced on Aug. 2, 2021, after 27 years of marriage. When billionaires divorce, it can be a messy affair. Not so for the Seattle power couple. In May, the Bill & Melinda Gates Foundation announced that Melinda French Gates would leave the foundation and her role as co-chair.

by: Seeking Alpha

Tracking David Tepper's Appaloosa Management Portfolio - Q3 2024 Update

Read here for an analysis of David Tepper's latest investment moves: new stakes, disposals, stake increases, top holdings.

by: Seeking Alpha

ERH: This Fund Presents An Interesting Opportunity For Income Investors

ERH is an under-followed CEF that invests in a 70/30 portfolio of utility equities and junk bonds. Find out my recommendation for the fund.

by: 24/7 Wall St

Prediction: This Is When NVIDIA Will Split Its Stock Next

Nvidia (NASDAQ:NVDA) remains the hottest AI stock in the market, and remains the second-largest company by market capitalization in the world. That says a lot about this company, given its revenue relative to current market leader Apple (NADSAQ:AAPL),

by: Kiplinger

What to Know About Leverage and Bitcoin's Meteoric Rise

Leverage in the financial world can lead to astonishing success or a crushing collapse. How are investors using leverage to invest in bitcoin?

by: The Motley Fool

NextEra Energy: The Power of Dividend Growth Over Yield

What has dividend growth been worth at NextEra Energy? The highest price of NextEra Energy's stock in 2013 was roughly $22.45, adjusted for a 4-for-1 stock split in 2020. The dividend, also adjusted for the stock split, was $0.165 per share per quarter. So the dividend yield was 2.9%, slightly higher than the yield is today.

by: Seeking Alpha

Harbor International Compounders Fund Q3 2024 Commentary

During the quarter, the Harbor International Compounders Fund returned 4.40%, underperforming its primary benchmark.

by: Seeking Alpha

Mercedes-Benz: Why The Company Is Undervalued Here

Mercedes-Benz faces challenges but remains an undervalued premium brand with strong fundamentals and potential for recovery. Learn more on MBGAF stock here.

by: Seeking Alpha

Dividend Dynasty: My Blueprint For Market-Beating Returns

Dividend growth investing offers above-average returns with below-average risks. Read more to see my recommendations.

by: Seeking Alpha

SSAB: Difficult To Forecast The Future In Steel, But Appealing Below 50 SEK

SSAB AB (SSAAF) faces significant volatility and negative growth, with EPS expected to drop through 2025. See why I maintain a hold rating on the stock.

by: Seeking Alpha

VT: Simple Low-Cost Diversification

The Vanguard Total World Stock Market Fund is an all encompassing fund of stocks from across the globe. Read why I rate VT ETF a Hold.

by: Seeking Alpha

Phathom Pharmaceuticals: The Large Drop Is, Well, Unfathomable

Phathom Pharmaceuticals, Inc.'s vonoprazan received multiple approvals, but the stock price showed erratic behavior. Learn more on PHAT stock here.

by: MSN

The Ultimate Biotech Stock to Buy With $500 Right Now

Investing in biotech stocks isn't for everyone because the very nature of their business is fraught with risk. As a result, biotech stocks can be highly volatile. However, some exceptions aren't nearly as risky.

by: MSN

100% stocks for retirement? A new study says dump the 60/40 portfolio and target-date funds.

An all-equity portfolio, with a focus on international stocks, could be the key to maximizing retirement wealth, research suggests.

by: MSN

Needham names Stryker top pick for 2025 on new products, margin gains

Needham analyst named Stryker Corporation (NYSE:SYK) its top pick for 2025, highlighting growth potential from new products, margin improvements, and expected M&A activity. Raised its price target on the stock to $442

by: MSN

Best focused mutual funds to invest in December 2024

According to Sebi norms, focused equity mutual fund schemes must invest in a portfolio of maximum 30 stocks. These schemes have no other restrictions when it comes to investing- like flexi cap schemes they can invest in any market capitalisations and sectors.

by: MSN

Cathie Wood sells $7 million of surging stock

Wood says these companies will transform industries, but their volatility causes significant swings in Ark funds' values. Related: Cathie Wood buys $22.1 million of battered tech

by: MSN

Here's Why it is Worth Investing in RBC Bearings Stock Now

RBC Bearings Incorporated RBC stands to benefit from strength across its businesses, synergies from acquisitions and shareholder-friendly policies. The company remains focused on investing in growth opportunities and strengthening its long-term market position.

by: MSN

I'm 54 and Retiring Soon. How Should I Structure My $1.6 Million Portfolio?

Early retirement is different. Every retirement plan is based on a combination of goals, risks and personal budget. You want to build a portfolio for security, so you never need to worry about money again,

by: MSN

Here's How Much a $25,000 Investment in the S&P 500 at the Start of 2025 Could Grow to Be Worth in 25 Years

For decades, investing in the stock market has been an excellent way for investors to accumulate wealth. And the S&P 500 (SNPINDEX: ^GSPC) specifically has given investors an efficient way to tap into the best stocks in the world.

by: MSN

Is U.S. Bancorp (USB) the Best Bank Stock to Invest in for the Long Term?

We recently published a list of 10 Best Bank Stocks To Invest In For the Long Term. In this article, we are going to take a look at where U.S. Bancorp (NYSE:USB) stands against other best bank stocks to invest in for the long term.

by: MSN

5 Gold Stocks Set to Shine as Yellow Metal's Rebound Sets Stage for Bullish 2025

Following a sharp fall post Trump's election as US president, Gold has posted a solid rebound. Several factors suggest that the metal will continue to rise in 2025. Let's take a look at 5 stocks that could benefit from gold's potential run.

by: MSN

Zomato QIP, Swiggy IPO to Reliance Industries: Where did mutual funds invest most in November?

November saw mutual funds allocate ₹26,400 crore to stocks, with Zomato and Swiggy leading investments. However, mutual funds sold ₹11,000 crore in HDFC Bank.

Phathom Pharmaceuticals: The Large Drop Is, Well, Unfathomable

Phathom Pharmaceuticals, Inc.'s vonoprazan received multiple approvals, but the stock price showed erratic behavior. Learn more on PHAT stock here.
The article from Seeking Alpha discusses the significant drop in Phathom Pharmaceuticals' stock price, which the author finds surprising and potentially unwarranted. Phathom Pharmaceuticals, a company focused on developing treatments for gastrointestinal diseases, experienced a sharp decline in its stock value following the announcement of a delay in the resubmission of its New Drug Application (NDA) for vonoprazan, a treatment for erosive esophagitis. The delay was due to the detection of a nitrosamine impurity, which required further investigation and remediation. Despite this setback, the author argues that the market's reaction might be overblown, considering the company's proactive approach to addressing the issue, the potential of vonoprazan in the market, and the company's other ongoing projects. The article suggests that while there are risks, the long-term outlook for Phathom could still be positive, especially if they manage to resolve the impurity issue and successfully bring vonoprazan to market.

Read the Full Seeking Alpha Article at:
https://seekingalpha.com/article/4743721-phathom-pharmaceuticals-the-large-drop-is-well-unfathomable